4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000218
Director sold 2,750 shares at $83.13 ($228,605)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLETTA MARK G Director | 2025-06-16 | Sale 10b5-1 | −2,750 | $83.13 | $228,605 | 56,621 | I: show line 1 in the form |
| Open-market sales · 2,750 sh · avg $83.13 · $228,605 | |||||||
Loading xslF345X05/wk-form4_1750278712.xml…